U.S. Markets closed

Antares Pharma (ATRS) Raised to “Hold” at ValuEngine

The Cerbat Gem

ValuEngine upgraded shares of Antares Pharma (NASDAQ:ATRS) from a sell rating to a hold rating in a research note issued to investors on Friday morning. ATRS has been the subject of a number of other research reports. BidaskClub raised Antares Pharma from a hold rating to a buy rating in a research report